Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kiyoi, H; Naoe, T
   Immunoglobulin variable region structure and B-cell malignancies
   INTERNATIONAL JOURNAL OF HEMATOLOGY
   
   H. Kiyoi e T. Naoe, "Immunoglobulin variable region structure and B-cell malignancies", INT J HEMAT, 73(1), 2001, pp. 47-53
2. Hanamura, I; Iida, S; Akano, Y; Hayami, Y; Kato, M; Miura, K; Harada, S; Banno, S; Wakita, A; Kiyoi, H; Naoe, T; Shimizu, S; Sonta, S; Nitta, M; Taniwaki, M; Ueda, R
   Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations
   JAPANESE JOURNAL OF CANCER RESEARCH
   
   I. Hanamura et al., "Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations", JPN J CANC, 92(6), 2001, pp. 638-644
3. Naoe, T; Kiyoi, H; Yamamoto, Y; Minami, Y; Yamamoto, K; Ueda, R; Saito, H
   FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy
   CANCER CHEMOTHERAPY AND PHARMACOLOGY
   
   T. Naoe et al., "FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy", CANC CHEMOT, 48, 2001, pp. S27-S30
4. Hirose, Y; Kiyoi, H; Itoh, K; Kato, K; Saito, H; Naoe, T
   B-cell precursors differentiated from cord blood CD34(+) cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34(+) cells
   IMMUNOLOGY
   
   Y. Hirose et al., "B-cell precursors differentiated from cord blood CD34(+) cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34(+) cells", IMMUNOLOGY, 104(4), 2001, pp. 410-417
5. Yamamoto, Y; Kiyoi, H; Nakano, Y; Suzuki, R; Kodera, Y; Miyawaki, S; Asou, N; Kuriyama, K; Yagasaki, F; Shimazaki, C; Akiyama, H; Saito, K; Nishimura, M; Motoji, T; Shinagawa, K; Takeshita, A; Saito, H; Ueda, R; Ohno, R; Naoe, T
   Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
   BLOOD
   
   Y. Yamamoto et al., "Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies", BLOOD, 97(8), 2001, pp. 2434-2439
6. Naoe, T; Takeyama, K; Yokozawa, T; Kiyoi, H; Seto, M; Uike, N; Ino, T; Utsunomiya, A; Maruta, A; Jin-Nai, I; Kamada, N; Kubota, Y; Nakamura, H; Shimazaki, C; Horiike, S; Kodera, Y; Saito, H; Ueda, R; Wiemels, J; Ohno, R
   Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related Leukemia/Myelodysplastic Syndrome and de novo acute myeloid leukemia
   CLINICAL CANCER RESEARCH
   
   T. Naoe et al., "Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related Leukemia/Myelodysplastic Syndrome and de novo acute myeloid leukemia", CLIN CANC R, 6(10), 2000, pp. 4091-4095
7. Naoe, T; Nakano, Y; Kiyoi, H
   Leukemia relapse reconsidered from the molecular aspect
   LEUKEMIA & LYMPHOMA
   
   T. Naoe et al., "Leukemia relapse reconsidered from the molecular aspect", LEUK LYMPH, 37(5-6), 2000, pp. 527-534
8. Hayakawa, F; Towatari, M; Kiyoi, H; Tanimoto, M; Kitamura, T; Saito, H; Naoe, T
   Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines
   ONCOGENE
   
   F. Hayakawa et al., "Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines", ONCOGENE, 19(5), 2000, pp. 624-631
9. Nakano, Y; Naoe, T; Kiyoi, H; Kitamura, K; Minami, S; Miyawaki, S; Asou, N; Kuriyama, K; Kusumoto, S; Shimazaki, C; Akiyama, H; Saito, K; Nishimura, M; Motoji, T; Shinagawa, K; Saito, H; Ohno, R
   Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia
   EUROPEAN JOURNAL OF HAEMATOLOGY
   
   Y. Nakano et al., "Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia", EUR J HAEMA, 65(1), 2000, pp. 23-31
10. Zhao, M; Kiyoi, H; Yamamoto, Y; Ito, M; Towatari, M; Omura, S; Kitamura, T; Ueda, R; Saito, H; Naoe, T
    In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor
    LEUKEMIA
    
    M. Zhao et al., "In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor", LEUKEMIA, 14(3), 2000, pp. 374-378
11. Kitamura, K; Minami, Y; Yamamoto, K; Akao, Y; Kiyoi, H; Saito, H; Naoe, T
    Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis
    LEUKEMIA
    
    K. Kitamura et al., "Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis", LEUKEMIA, 14(10), 2000, pp. 1743-1750
12. Yokozawa, T; Towatari, M; Iida, H; Takeyama, K; Tanimoto, M; Kiyoi, H; Motoji, T; Asou, N; Saito, K; Takeuchi, M; Kobayashi, Y; Miyawaki, S; Kodera, Y; Ohno, R; Saito, H; Naoe, T
    Prognostic significance of the cell cycle inhibitor p27(Kip1) in acute myeloid leukemia
    LEUKEMIA
    
    T. Yokozawa et al., "Prognostic significance of the cell cycle inhibitor p27(Kip1) in acute myeloid leukemia", LEUKEMIA, 14(1), 2000, pp. 28-33
13. Nakano, Y; Naoe, T; Kiyoi, H; Kunishima, S; Minami, S; Miyawaki, S; Asou, N; Kuriyama, K; Saito, H; Ohno, R
    Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia
    LEUKEMIA RESEARCH
    
    Y. Nakano et al., "Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia", LEUK RES, 24(4), 2000, pp. 349-352
14. Kitamura, K; Hoshi, S; Koike, M; Kiyoi, H; Saito, H; Naoe, T
    Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid
    BRITISH JOURNAL OF HAEMATOLOGY
    
    K. Kitamura et al., "Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid", BR J HAEM, 108(4), 2000, pp. 696-702
15. Koch, P; Bohlmann, I; Schafer, M; Hansen-Hagge, TE; Kiyoi, H; Wilda, M; Hameister, H; Bartram, CR; Janssen, JWG
    Identification of a novel putative Ran-binding protein and its close homologue
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    P. Koch et al., "Identification of a novel putative Ran-binding protein and its close homologue", BIOC BIOP R, 278(1), 2000, pp. 241-249
16. Kosugi, H; Towatari, M; Hatano, S; Kitamura, K; Kiyoi, H; Kinoshita, T; Tanimoto, M; Murate, T; Kawashima, K; Saito, H; Naoe, T
    Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy
    LEUKEMIA
    
    H. Kosugi et al., "Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy", LEUKEMIA, 13(9), 1999, pp. 1316-1324
17. Kiyoi, H; Naoe, T
    Reply - Review of the immunoglobulin light chain variable region sequencesfrom multiple myeloma cells
    LEUKEMIA
    
    H. Kiyoi e T. Naoe, "Reply - Review of the immunoglobulin light chain variable region sequencesfrom multiple myeloma cells", LEUKEMIA, 13(5), 1999, pp. 829-830
18. Iida, M; Towatari, M; Nakao, A; Iida, H; Kiyoi, H; Nakano, Y; Tanimoto, M; Saito, H; Naoe, T
    Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation
    LEUKEMIA
    
    M. Iida et al., "Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation", LEUKEMIA, 13(4), 1999, pp. 585-589
19. Mizuta, S; Ito, Y; Kohno, A; Kiyoi, H; Miyamura, K; Tanimoto, M; Takamatsu, J; Naoe, T; Morishima, Y; Ueda, R; Saito, H
    Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    S. Mizuta et al., "Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation", BONE MAR TR, 24(7), 1999, pp. 777-784
20. Nakano, Y; Kiyoi, H; Miyawaki, S; Asou, N; Ohno, R; Saito, H; Naoe, T
    Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene
    BRITISH JOURNAL OF HAEMATOLOGY
    
    Y. Nakano et al., "Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene", BR J HAEM, 104(4), 1999, pp. 659-664
21. Kiyoi, H; Naoe, T; Nakano, Y; Yokota, S; Minami, S; Miyawaki, S; Asou, N; Kuriyama, K; Jinnai, I; Shimazaki, C; Akiyama, H; Saito, K; Oh, H; Motoji, T; Omoto, E; Saito, H; Ohno, R; Ueda, R
    Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia
    BLOOD
    
    H. Kiyoi et al., "Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia", BLOOD, 93(9), 1999, pp. 3074-3080
22. TAKAHASHI Y; HORIBE K; KIYOI H; MIYASHITA Y; FUKUDA M; MORI H; NOZAKI C; HASEGAWA S; KAWABE T; KATO K; KOJIMA S; MATUYAMA T; NAOE T
    PROGNOSTIC-SIGNIFICANCE OF TEL AML1 FUSION TRANSCRIPT IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA/
    Journal of pediatric hematology/oncology
    
    Y. Takahashi et al., "PROGNOSTIC-SIGNIFICANCE OF TEL AML1 FUSION TRANSCRIPT IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA/", Journal of pediatric hematology/oncology, 20(3), 1998, pp. 190-195
23. KIYOI H; TOWATARI M; YOKOTA S; HAMAGUCHI M; OHNO R; SAITO H; NAOE T
    INTERNAL TANDEM DUPLICATION OF THE FLT3 GENE IS A NOVEL MODALITY OF ELONGATION MUTATION WHICH CAUSES CONSTITUTIVE ACTIVATION OF THE PRODUCT
    Leukemia
    
    H. Kiyoi et al., "INTERNAL TANDEM DUPLICATION OF THE FLT3 GENE IS A NOVEL MODALITY OF ELONGATION MUTATION WHICH CAUSES CONSTITUTIVE ACTIVATION OF THE PRODUCT", Leukemia, 12(9), 1998, pp. 1333-1337
24. KUDO K; YOSHIDA H; KIYOI H; NUMATA S; HORIBE K; NAOE T
    ETOPOSIDE-RELATED ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    K. Kudo et al., "ETOPOSIDE-RELATED ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 12(8), 1998, pp. 1171-1175
25. KIYOI H; NAITO K; OHNO R; SAITO H; NAOE T
    CHARACTERIZATION OF THE IMMUNOGLOBULIN LIGHT-CHAIN VARIABLE REGION GENE EXPRESSED IN MULTIPLE-MYELOMA
    Leukemia
    
    H. Kiyoi et al., "CHARACTERIZATION OF THE IMMUNOGLOBULIN LIGHT-CHAIN VARIABLE REGION GENE EXPRESSED IN MULTIPLE-MYELOMA", Leukemia, 12(4), 1998, pp. 601-609
26. HAYAKAWA F; TOWATARI M; IIDA H; WAKAO H; KIYOI H; NAOE T; SAITO H
    DIFFERENTIAL CONSTITUTIVE ACTIVATION BETWEEN STAT-RELATED PROTEINS AND MAP KINASE IN PRIMARY ACUTE MYELOGENOUS LEUKEMIA
    British Journal of Haematology
    
    F. Hayakawa et al., "DIFFERENTIAL CONSTITUTIVE ACTIVATION BETWEEN STAT-RELATED PROTEINS AND MAP KINASE IN PRIMARY ACUTE MYELOGENOUS LEUKEMIA", British Journal of Haematology, 101(3), 1998, pp. 521-528
27. KIYOI H; NAOE T; YOKOTA S; NAKAO M; MINAMI S; KURIYAMA K; TAKESHITA A; SAITO K; HASEGAWA S; SHIMODAIRA S; TAMURA J; SHIMAZAKI C; MATSUE K; KOBAYASHI H; ARIMA N; SUZUKI R; MORISHITA H; SAITO H; UEDA R; OHNO R
    INTERNAL TANDEM DUPLICATION OF FLT3 ASSOCIATED WITH LEUKOCYTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    H. Kiyoi et al., "INTERNAL TANDEM DUPLICATION OF FLT3 ASSOCIATED WITH LEUKOCYTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 11(9), 1997, pp. 1447-1452
28. MORI H; KIYOI H; HORIBE K; OHNO R; NAOE T
    COMPARISON OF THE IMMUNOGLOBULIN GENE TRANSCRIPTS BETWEEN IMMATURE B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA AND THE NORMAL PHENOTYPIC COUNTERPARTS IN THE BONE-MARROW
    Leukemia
    
    H. Mori et al., "COMPARISON OF THE IMMUNOGLOBULIN GENE TRANSCRIPTS BETWEEN IMMATURE B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA AND THE NORMAL PHENOTYPIC COUNTERPARTS IN THE BONE-MARROW", Leukemia, 11(8), 1997, pp. 1274-1280
29. KITAMURA K; KIYOI H; YOSHIDA H; SAITO H; OHNO R; NAOE T
    MUTANT AF-2 DOMAIN OF PML-RAR-ALPHA IN RETINOIC ACID-RESISTANT NB4 CELLS - DIFFERENTIATION-INDUCED BY RA IS TRIGGERED DIRECTLY THROUGH PML-RAR-ALPHA AND ITS DOWN-REGULATION IN ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    K. Kitamura et al., "MUTANT AF-2 DOMAIN OF PML-RAR-ALPHA IN RETINOIC ACID-RESISTANT NB4 CELLS - DIFFERENTIATION-INDUCED BY RA IS TRIGGERED DIRECTLY THROUGH PML-RAR-ALPHA AND ITS DOWN-REGULATION IN ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 11(11), 1997, pp. 1950-1956
30. YOKOTA S; KIYOI H; NAKAO M; IWAI T; MISAWA S; OKUDA T; SONODA Y; ABE T; KAHSIMA K; MATSUO Y; NAOE T
    INTERNAL TANDEM DUPLICATION OF THE FLT3 GENE IS PREFERENTIALLY SEEN IN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME AMONG VARIOUS HEMATOLOGICAL MALIGNANCIES - A STUDY ON A LARGE SERIES OF PATIENTS AND CELL-LINES
    Leukemia
    
    S. Yokota et al., "INTERNAL TANDEM DUPLICATION OF THE FLT3 GENE IS PREFERENTIALLY SEEN IN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME AMONG VARIOUS HEMATOLOGICAL MALIGNANCIES - A STUDY ON A LARGE SERIES OF PATIENTS AND CELL-LINES", Leukemia, 11(10), 1997, pp. 1605-1609
31. KITAMURA K; KIYOI H; YOSHIDA H; TOBITA T; TAKESHITA A; OHNO R; NAOE T
    NEW RETINOIDS AND ARSENIC COMPOUNDS FOR THE TREATMENT OF REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA - CLINICAL AND BASIC STUDIES FOR THE NEXT-GENERATION
    Cancer chemotherapy and pharmacology
    
    K. Kitamura et al., "NEW RETINOIDS AND ARSENIC COMPOUNDS FOR THE TREATMENT OF REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA - CLINICAL AND BASIC STUDIES FOR THE NEXT-GENERATION", Cancer chemotherapy and pharmacology, 40, 1997, pp. 36-41
32. YAMANAKA K; KUBO K; KIYOI H; ICHIHASHI T; KATO K; HORIBE K; NAOE T
    UNUSUAL FEATURE OF THE T-CELL RECEPTOR GENES IN T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA
    Leukemia research
    
    K. Yamanaka et al., "UNUSUAL FEATURE OF THE T-CELL RECEPTOR GENES IN T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA", Leukemia research, 21(7), 1997, pp. 667-674
33. KUDO K; YOSHIDA H; KIYOI H; HORIBE K; NAOE T; MURATE T
    CLUSTERED BREAKPOINTS OF T(15-17) IN ETOPOSIDE-RELATED ACUTE PROMYELOCYTIC LEUKEMIA PRECEDED BY LANGERHANS CELL HISTIOCYTOSIS
    Blood
    
    K. Kudo et al., "CLUSTERED BREAKPOINTS OF T(15-17) IN ETOPOSIDE-RELATED ACUTE PROMYELOCYTIC LEUKEMIA PRECEDED BY LANGERHANS CELL HISTIOCYTOSIS", Blood, 90(10), 1997, pp. 3575-3575
34. KIYOI H; NAITO K; OHNO R; NAOE T
    COMPARABLE GENE STRUCTURE OF THE IMMUNOGLOBULIN HEAVY-CHAIN VARIABLE REGION BETWEEN MULTIPLE-MYELOMA AND NORMAL BONE-MARROW LYMPHOCYTES
    Leukemia
    
    H. Kiyoi et al., "COMPARABLE GENE STRUCTURE OF THE IMMUNOGLOBULIN HEAVY-CHAIN VARIABLE REGION BETWEEN MULTIPLE-MYELOMA AND NORMAL BONE-MARROW LYMPHOCYTES", Leukemia, 10(11), 1996, pp. 1804-1812
35. KIYOI H; MORI H; HORIBE K; OHNO R; NAOE T
    COMPARISON OF THE IMMUNOGLOBULIN HEAVY-CHAIN COMPLEMENTARITY-DETERMINING REGION-3 STRUCTURE AMONG THE DNA-SEQUENCES AND THE MU-TRANSCRIPT AND GAMMA-TRANSCRIPT IN HUMAN B-LINEAGE CELLS
    Immunology
    
    H. Kiyoi et al., "COMPARISON OF THE IMMUNOGLOBULIN HEAVY-CHAIN COMPLEMENTARITY-DETERMINING REGION-3 STRUCTURE AMONG THE DNA-SEQUENCES AND THE MU-TRANSCRIPT AND GAMMA-TRANSCRIPT IN HUMAN B-LINEAGE CELLS", Immunology, 89(3), 1996, pp. 324-330
36. KUBO K; YAMANAKA K; KIYOI H; FUKUTANI H; ITO M; HAYAKAWA R; OHNO R; NAOE T
    DIFFERENT T-CELL RECEPTOR REPERTOIRES BETWEEN LESIONS AND PERIPHERAL-BLOOD IN ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    Blood
    
    K. Kubo et al., "DIFFERENT T-CELL RECEPTOR REPERTOIRES BETWEEN LESIONS AND PERIPHERAL-BLOOD IN ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION", Blood, 87(7), 1996, pp. 3019-3026
37. YOSHIDA H; NAOE T; FUKUTANI H; KIYOI H; KUBO K; OHNO R
    ANALYSIS OF THE JOINING SEQUENCES OF THE T(15-17) TRANSLOCATION IN HUMAN ACUTE PROMYELOCYTIC LEUKEMIA - SEQUENCE NONSPECIFIC RECOMBINATION BETWEEN THE PML AND RARA GENES WITHIN IDENTICAL SHORT STRETCHES
    Genes, chromosomes & cancer
    
    H. Yoshida et al., "ANALYSIS OF THE JOINING SEQUENCES OF THE T(15-17) TRANSLOCATION IN HUMAN ACUTE PROMYELOCYTIC LEUKEMIA - SEQUENCE NONSPECIFIC RECOMBINATION BETWEEN THE PML AND RARA GENES WITHIN IDENTICAL SHORT STRETCHES", Genes, chromosomes & cancer, 12(1), 1995, pp. 37-44
38. FUKUTANI H; NAOE T; OHNO R; YOSHIDA H; KIYOI H; MIYAWAKI S; MORISHITA H; SANO F; KAMIBAYASHI H; MATSUE K; MIYAKE T; HASEGAWA S; UEDA Y; KATO Y; KOBAYASHI H; SHIMAZAKI C; KOBAYASHI M; KURANE R; SAKOTA H; MASAKI K; WAKAYAMA T; TOHYAMA K; NONAKA Y; NATORI H
    PROGNOSTIC-SIGNIFICANCE OF THE RT-PCR ASSAY OF PML-RARA TRANSCRIPTS IN ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    H. Fukutani et al., "PROGNOSTIC-SIGNIFICANCE OF THE RT-PCR ASSAY OF PML-RARA TRANSCRIPTS IN ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 9(4), 1995, pp. 588-593
39. KIYOI H; FUKUTANI H; YAMAUCHI T; KUBO K; OHNO R; YAMAMORI S; NAOE T
    CONTINUING IMMUNOGLOBULIN HEAVY-CHAIN GENE REARRANGEMENTS IN CHRONIC MYELOID-LEUKEMIA WITH RECURRENT B-LYMPHOID BLAST CRISES AFTER BONE-MARROW TRANSPLANTATION
    Leukemia
    
    H. Kiyoi et al., "CONTINUING IMMUNOGLOBULIN HEAVY-CHAIN GENE REARRANGEMENTS IN CHRONIC MYELOID-LEUKEMIA WITH RECURRENT B-LYMPHOID BLAST CRISES AFTER BONE-MARROW TRANSPLANTATION", Leukemia, 9(2), 1995, pp. 265-270
40. KIYOI H; KOJIMA S; KATO K; MATSUYAMA T; KODERA Y; OHNO R; NAOE T
    DETECTION OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CHILDHOOD COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH EX-VIVO PURGING AND SYSTEMIC IL-2 INFUSION - UNSUCCESSFUL PREDICTION OF SUBSEQUENT RELAPSE
    Bone marrow transplantation
    
    H. Kiyoi et al., "DETECTION OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CHILDHOOD COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH EX-VIVO PURGING AND SYSTEMIC IL-2 INFUSION - UNSUCCESSFUL PREDICTION OF SUBSEQUENT RELAPSE", Bone marrow transplantation, 16(3), 1995, pp. 437-442
41. KIYOI H; NAITO K; OHNO R; NAOE T
    COMPARABLE PROFILES OF THE IMMUNOGLOBULIN HEAVY-CHAIN COMPLEMENTARITY-DETERMINING REGION (CDR)-3 IN CD5(-) HUMAN CORD-BLOOD B-LYMPHOCYTES()AND CD5()
    Immunology
    
    H. Kiyoi et al., "COMPARABLE PROFILES OF THE IMMUNOGLOBULIN HEAVY-CHAIN COMPLEMENTARITY-DETERMINING REGION (CDR)-3 IN CD5(-) HUMAN CORD-BLOOD B-LYMPHOCYTES()AND CD5()", Immunology, 85(2), 1995, pp. 236-240
42. KIYOI H; FUKUTANI H; KUBO K; OHNO R; NAOE T
    CHARACTERIZATION OF IMMUNOGLOBULIN HEAVY-CHAIN GENE REARRANGEMENTS INCHRONIC MYELOID-LEUKEMIA WITH RECURRENT B-LYMPHOID BLAST CRISIS FOLLOWING BONE-MARROW TRANSPLANTATION
    Internal medicine
    
    H. Kiyoi et al., "CHARACTERIZATION OF IMMUNOGLOBULIN HEAVY-CHAIN GENE REARRANGEMENTS INCHRONIC MYELOID-LEUKEMIA WITH RECURRENT B-LYMPHOID BLAST CRISIS FOLLOWING BONE-MARROW TRANSPLANTATION", Internal medicine, 33(12), 1994, pp. 786-789
43. KUBO K; NAOE T; KIYOI H; FUKUTANI H; KATO Y; OGURI T; YAMAMORI S; AKATSUKA Y; KODERA Y; OHNO R
    CLONAL ANALYSIS OF MULTIPLE POINT MUTATIONS IN THE N-RAS GENE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    Japanese journal of cancer research
    
    K. Kubo et al., "CLONAL ANALYSIS OF MULTIPLE POINT MUTATIONS IN THE N-RAS GENE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA", Japanese journal of cancer research, 84(4), 1993, pp. 379-387
44. KIYOI H; NAOE T; YAMAUCHI T; FUKATANI H; KUBO K; KOJIMA S; OHNO R
    MINIMAL RESIDUAL DISEASE STATUS IN PRE-B ACUTE LYMPHOBLASTIC-LEUKEMIAPATIENTS AFTER CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION - ASSESSMENT OF THE ANTILEUKEMIC EFFECTS OF CHEMOTHERAPY AND BMT
    Leukemia research
    
    H. Kiyoi et al., "MINIMAL RESIDUAL DISEASE STATUS IN PRE-B ACUTE LYMPHOBLASTIC-LEUKEMIAPATIENTS AFTER CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION - ASSESSMENT OF THE ANTILEUKEMIC EFFECTS OF CHEMOTHERAPY AND BMT", Leukemia research, 17(8), 1993, pp. 677-684
45. NAOE T; KUBO K; KIYOI H; OHNO R; AKAO Y; YOSHIDA J; KATO K; KOJIMA S; MATSUYAMA T
    INVOLVEMENT OF THE MLL ALL-1 GENE ASSOCIATED WITH MULTIPLE POINT MUTATIONS OF THE N-RAS GENE IN ACUTE MYELOID-LEUKEMIA WITH T(11 17)(Q23 Q25)/
    Blood
    
    T. Naoe et al., "INVOLVEMENT OF THE MLL ALL-1 GENE ASSOCIATED WITH MULTIPLE POINT MUTATIONS OF THE N-RAS GENE IN ACUTE MYELOID-LEUKEMIA WITH T(11 17)(Q23 Q25)/", Blood, 82(7), 1993, pp. 2260-2261